Chemistry

Quotient Bioresearch provides a range of chemistry services to support drug discovery and development, and any other studies investigating the metabolism, toxicology and environmental fate of new and established chemicals.

Radiosynthesis

Amersham* Radiolabelling Services was acquired by Quotient Bioresearch from GE Healthcare in June 2009; the service now trades under the brand Quotient Amersham Radiochemicals.

Custom Radiolabelling

With world class facilities and chemists having over 1,600 man-years' experience in radiosynthesis, Quotient Bioresearch offers unparalleled resources for the custom synthesis of isotopically labelled compounds.

GMP Radiosynthesis

UK MHRA accredited GMP facility with successful GMP inspections in September 2004, August 2006 and September 2008.

Intermediates

¹⁴C labelled intermediates for radiochemical synthesis can be supplied in bulk quantities to customer specifications on request.

Chemical Synthesis

Quotient Bioresearch applies its wide experience of synthetic route development gained in custom isotope synthesis to conventional organic synthesis and can develop novel laboratory-scale routes to potential drug candidates and supply:

Samples of metabolite reference compounds
Samples of manufacturing impurity standards
Multi-gram quantities of potential drug candidate.

MHRA - Medicines and Healthcare products Regulatory Agency; GMP - Good Manufacturing Practice.